Related by context. All words. (Click for frequent words.) 81 Secures Exclusive 81 Reacquires 80 Obtains Exclusive 78 Signs Licensing Agreement 77 Receives Patent 77 Announces License Agreement 77 Announce License Agreement 77 Announce Licensing Agreement 77 Signs License Agreement 76 Announces Licensing Agreement 76 Announces Initiation 76 Closes Acquisition 75 Sign Licensing Agreement 75 Announces FDA Clearance 75 Announce Exclusive 75 Files Patent Application 75 Announces Issuance 74 Subsidiary Enters 74 Receives Milestone Payment 74 Licenses Novel 74 Sign License Agreement 74 Finalizes Acquisition 74 Enters Agreement 74 Announces Acquisition 74 Regains Full 74 Announces Termination 74 Signs Exclusive 74 Announces Signing 74 Receives Orphan Drug Designation 74 Awarded Patent 74 Initiates Phase II 73 Obtains License 73 Reports Positive 73 Announces Formation 73 Announce Merger Agreement 73 Announces Successful Completion 73 Announce Collaboration 73 Secures Financing 73 Acquires Assets 73 Enters Into Agreement 73 Aquires 73 FDA Clears 73 Spins Off 73 Closes Acquisition Of 73 Announces Definitive Agreement 72 Completes Patient Enrollment 72 Announces Expanded 72 Files Shelf Registration Statement 72 Begins Shipment 72 Expands Distribution 72 Jointly Announce 72 Completes Purchase 72 Acquires 72 Discontinues 72 Completes Acquisition 72 Q3 Loss Widens 72 Announce Collaboration Agreement 72 Enrolls First 72 Enters Into Licensing Agreement 72 Submits Application 72 Announce Commencement 72 Commercialize 72 Inks Pact 72 Acquires Controlling Interest 72 Files IND 72 Announces Commencement 72 Acquire Assets 72 Enters Into License Agreement 72 Completes Initial 72 Enters Into Exclusive 72 Obtains Exclusive License 72 Subsidiary Acquires 72 Exercises Option 72 Completes Merger With 72 Amends Agreement 72 Receives FDA Clearance 72 Completes Enrollment 72 Announces Positive 72 Shows Promise 71 Enter Into 71 Finalizes Agreement 71 Initiates Clinical Trial 71 Provides Update Regarding 71 Achieves Significant 71 Presents Positive 71 Unveils Innovative 71 Q3 Loss Narrows 71 Shareholders Approve Acquisition 71 Inks Deal With 71 Introduces Revolutionary 71 Announces Shareholder Approval 71 Announces Immediate Availability 71 Secures Long Term 71 Completes Private Placement 71 Announces Divestiture 71 Initiates Enrollment 71 Successfully Completes Tender Offer 71 Enters Into Strategic 71 Acquirer Company 71 Closes Sale 71 Announce Agreement 71 Inks Distribution 71 Q2 Loss Narrows 71 Consummates 71 Completes Merger 71 Closes Previously Announced 71 Achieves Milestone 71 Receives Approvable Letter 71 Secures Funding 71 Announce Licensing 71 Secures Additional 71 Q2 Loss Widens 71 Increases Ownership 71 Signs Distribution 71 Enters Into Letter 71 Signs Agreements 71 Completes Acquisitions 71 Closes Financing 71 Q1 Loss Narrows 71 Inks Deals 71 Completes Tender Offer 71 Sinks Lower 70 Expand Relationship 70 Inks Exclusive 70 Unveils Revolutionary 70 Begins Shipping 70 Q4 Loss Narrows 70 Receives Favorable 70 Introduces Next Generation 70 Signs Long Term 70 Officially Launches 70 Broadens Its 70 Announce Completion 70 Completes Sale 70 Develop Novel 70 Ink Deal 70 Licensing Deal 70 Announces Successful 70 Executes Agreement 70 Receives Approval 70 Acquires Majority 70 Licensing Pact 70 Begins Dosing 70 Awarded Patents 70 Completes Financing 70 Announces Additions 70 Introduces Breakthrough 70 Jumps Higher 70 Strengthens Its 70 Announces Completion 70 Submits Biologics License Application 70 Settle Patent Litigation 70 Q1 Loss Widens 70 Announce Joint Venture 70 Monetizes 70 Finalizes Purchase 70 Attains 70 Announces Effective Date 70 Extends Expiration Date 70 Provides Shareholder 70 Presents Preclinical Data 70 Obtains Approval 70 Therapeutic Competitors Companies 70 Receives Positive 70 Receives Conditional 70 Announce Early Termination 70 Announces Early Termination 70 Updates Shareholders 70 Patent Issued 70 Gets FDA Clearance 69 Releases Next Generation 69 Rated Speculative Buy 69 Reports Receipt 69 Announces Sponsorship 69 Announces Launch 69 Commercializes 69 Inks Licensing Deal 69 Snaps Up 69 Q4 Loss Widens 69 Completes Transition 69 Completes Successful 69 Announces Presentation 69 Announces Favorable 69 Rebrands 69 Announces Revised 69 Files Patent 69 Announces Private Placement 69 Signs Definitive 69 Announces Closing 69 Initiates Clinical 69 Successfully Completes 69 Renews Agreement 69 Appoints Experienced 69 Voluntarily Withdraw 69 Explore Strategic Alternatives 69 Signs Licensing 69 Develop Next Generation 69 Restructures 69 Receives Clearance 69 Submits IND 69 Commences Phase 69 Completes Previously Announced 69 Launches Innovative 69 Launches Enhanced 69 Announces Receipt 69 Terminates Agreement 69 Spins Out 69 Announces Dismissal 69 Announces Proposed Acquisition 69 FY# Loss Widens 69 Collaborates With 69 Regains Compliance 69 Settle Patent Dispute 69 Announces Underwriters Exercise 69 Updates Status 69 Provides Updates 69 Changes Name 69 Enters Strategic 69 Submits NDA 69 Board Authorizes 69 Completes Asset 69 Jointly Develop 69 Appoints Seasoned 69 Completes Reverse Merger 69 Further Strengthens 69 Drug Candidate 69 BioSante Pharmaceuticals Announces 69 Awarded Multi 69 CybeRelease Decliners 69 Announces Preliminary 69 Develops Innovative 69 Successfully Closes 69 Regains Compliance With 69 Receives Regulatory 69 Announce Availability 69 Receives Confirmation 69 Extends Collaboration 69 Introduces Enhanced 69 Exclusive Distribution 69 Announces Organizational Changes 69 Board Unanimously Rejects 69 Announce Strategic 69 Obtains Patent 69 Announce Receipt 69 Extend Partnership 69 Unveils Latest 69 Launches Next Generation 68 Adopts Shareholder Rights 68 Expands Availability 68 Secures Patent 68 Closes Private Placement 68 Extends Tender Offer 68 Exclusive License 68 Commence Trading 68 Enters Into 68 Initiates Clinical Trials 68 Announces Addition 68 Achieves Positive 68 Inks Agreement 68 Successfully Complete 68 Completes Recapitalization 68 Reveals Positive 68 Announce Initiation 68 Initiates Dosing 68 Unveils Expanded 68 Announce Partnership 68 Subsidiary Enters Into 68 Receives Notification 68 Net Loss Widens 68 Significantly Expands 68 Announce Definitive Agreement 68 Announces Proposed 68 Inks Deal 68 Unveils Next Generation 68 Obtains 68 Announces Cancellation 68 Significantly Increases 68 Other OTC MNDP 68 Commences Tender Offer 68 Settles Litigation 68 Receives Commitment 68 Renews Exclusive 68 IIROC Halt 68 Files Registration Statement 68 Completes Purchase Of 68 Finalize Agreement 68 Announce Settlement 68 Completes Integration 68 Introduces Innovative 68 Strengthens Position 68 Taglich Brothers Initiates Coverage 68 Restructures Operations 68 Welcomes Analyst Initiation 68 Enters Joint Venture 68 Significantly Improves 68 FDA Approves 68 Announces Stockholder Approval 68 Provide Comprehensive 68 Inks Multi 68 Announces Enhancements 68 Terminate Merger Agreement 68 Receives Favorable Ruling 68 Extends Reach 68 Announces Availability 68 Signs Definitive Agreement 68 Present Preclinical Data 68 Enters Exclusive 68 Stockholders Approve Merger 68 Announces Publication 68 Successfully Concludes 68 Launches Unique 68 Announces Stock Repurchase 68 Expands Portfolio 68 Commences Trading 68 Receives Notice 68 Announces Expansion 67 Inc. OTCBB MNDP 67 FDA Okays 67 Launches Groundbreaking 67 Demonstrates Significant 67 Mutually Agree 67 Clarifies Status 67 Collaborators Present 67 Relaunches 67 Finalizes Sale 67 Restructures Debt 67 Settle Litigation 67 Complete Merger 67 Achieves ISO #:# Certification [002] 67 Receives Tentative Approval 67 Buys Majority Stake 67 Completes Divestiture 67 AllPennyStocks.com Spotlights 67 Signs LOI 67 Closes Second Tranche 67 Sells Shares 67 Revolutionizes 67 Expands Internationally 67 Announce Signing 67 Enters Negotiations 67 please visit http:/www.stockguru.com 67 Terminates Merger Agreement 67 Named Exclusive Distributor 67 Receives NASDAQ 67 Signs Agreement 67 Exploring Strategic Alternatives 67 Signs Merger Agreement 67 Sign Definitive Agreement 67 Formalizes 67 Subsidiary Signs 67 Net Loss Narrows 67 Forges Partnership 67 Announces Filing 67 Acquires Majority Stake 67 Settles Patent Dispute 67 IIROC Resume 67 Announce Expanded 67 Achieves Record Sales 67 Initiates Phase 67 Receives Order 67 Reconfirms 67 TheWallStreetLeader.com Profiles 67 Regains NASDAQ 67 Acquire Controlling Interest 67 Posts Strong 67 Announces Expiration 67 Completes Installation 67 Fortifies 67 Announces Discontinuation 67 Confirms Significant 67 Enters Into Definitive Agreement 67 Announces Non Brokered 67 Signs Pact 67 Expands Relationship With 67 Increases Stake 67 Successfully Completes Acquisition 67 Receives Orphan Drug 67 Expert Joins 67 Dramatically Increases 67 Settles Patent Litigation 67 Closes Merger 67 Acquires Remaining Interest 67 Successfully Completed 67 Announces Departure 67 Expands Into 67 Strengthens Balance Sheet 67 Delivers Next Generation 67 Confirms Commitment 67 Significantly Reduces 67 Signs Option Agreement 67 Amends Terms 67 Q4 Profit Surges 66 Unveils Groundbreaking 66 Announces Rebranding 66 www.otc advisors.com names 66 Distribution Pact 66 Signs Letter 66 DALLAS TEXAS StockGuru announces 66 Earnings Postmortem 66 Revitalizes 66 Announces Intent 66 Novartis Novo Nordisk 66 Wins Approval 66 Successfully Launches 66 Announce Expiration 66 Unveils Newest 66 TSX Delisting Review 66 Confirms Receipt 66 Shareholders Approve Sale 66 Retains Leading 66 Announces Normal Course 66 Releases Third Quarter 66 Expand Collaboration 66 Thewallstreetleader.com Profiles 66 Finalizes 66 Receives Certification 66 Secures 66 Extend Collaboration 66 Acacia Subsidiary Acquires 66 HSR Waiting Period 66 Report Initiates Independent 66 Attracting Bullish Investors 66 Commences Cash 66 Provides Clarification 66 Buy Privately Held 66 PRODUCT SOURCE 66 Receives SFDA Approval 66 Announces Tentative Approval 66 Stockholders Approve 66 Changes Ticker Symbol 66 Dutton Associates Announces 66 Announces Upcoming 66 Introduces Powerful 66 Retains Investor Relations 66 Signs Binding Letter 66 Completes Transaction 66 Voluntarily Withdraws 66 Penetrates 66 Achieves Record 66 Annouces 66 Extends Offer 66 Expands Scope 66 Subsidiary Receives 66 Terminates Contract 66 Procures 66 Licenses Patents 66 Successfully Tests 66 Scoops Up 66 Announces Recapitalization 66 Divests 66 Signs Lease 66 CONFERENCE CALLS EARNINGS SOURCE 66 Announce Formation 66 Acquire Remaining 66 Commences 66 Announces Share Repurchase 66 Engages Investor Relations 66 Announces Intention 66 Deliver Presentation 66 Reports Preclinical Data 66 Winning Streak Continues 66 Demonstrates Potential 66 Introduces Novel 66 DayTradersDigest.com Profiles 66 Secures Contract 66 Becomes Exclusive 66 Reduces Risk 66 AUDIO PROVIDED BY 66 Expands Presence 66 Takes Majority Stake 66 Refocuses 66 Furthers 66 Study Confirms 66 Patent Covering 66 Seeks Approval 66 Announces Redemption 66 Reacquire 66 Grants Options 66 Issued Patent 66 Submits Supplemental 66 More Than Doubles 66 Realigns 66 Acquire Privately Held 66 Announces Resumption 66 * vwd PRN 66 Continues Aggressive 66 Identifies Potential 66 Provides Update 66 Assets Acquirer Company 66 Signs Multi 66 Skymark Research Initiates Independent 66 Inc Therapeutic Competitors 66 Posts Wider Loss 66 Outlines Strategy 66 Presents Positive Preclinical 66 Launches Expanded 65 Shareholders Approve Merger 65 Obtains FDA 65 Anounces 65 Regains 65 Terminates 65 Introduces Expanded 65 Enters Into Joint Venture 65 Nasdaq SMTS develops manufactures 65 Dramatically Expands 65 Granted Orphan Drug 65 FY# Loss Narrows 65 Stockholders Approve Acquisition 65 Could Revolutionize 65 Announces Repurchase 65 Receives Conditional Approval 65 Files Preliminary Prospectus 65 Expands Reach 65 Receives Unsolicited 65 Signs Joint Venture 65 Host Third Quarter 65 Enters Oversold Territory 65 CONFERENCE CALLS SOURCE 65 Completes Expansion 65 Equity Preview 65 Announces Definitive Merger 65 Issues Statement Regarding 65 Enters Into Definitive 65 Releases Second Quarter 65 Other OTC USOG 65 Joins OTCQX 65 Nears Completion 65 Announces Adjournment 65 Streamlines Operations 65 Amend Merger Agreement 65 Concludes Acquisition 65 Reaches Milestone 65 PROFILE CO 65 Files Shelf Registration 65 Acquire Majority 65 Repositions 65 Bulks Up 65 Provides Updated 65 Reaches Agreement 65 Reports Profitable 65 Announces Ticker Symbol 65 Provides Preliminary 65 Unveils Breakthrough 65 MANAGEMENT CHANGES SOURCE 65 Launches Redesigned Website 65 Increases Size 65 Initiates Voluntary Recall 65 Reorganizes 65 Announces Postponement 65 Nasdaq ANPI 65 MONSTERSTOX.COM Monsterstox.com 65 Renegotiates 65 Launches Website 65 Buy Majority Stake 65 Announce Launch 65 Completes Restructuring 65 Reduces Debt 65 Continues Expansion 65 Submits Response 65 Expands Capabilities 65 CRWESelect CRWESelect.com Highlights 65 Shows Promising 65 Successfully Demonstrates 65 Gobbles Up 65 Completes Redemption 65 Forms Joint Venture 65 Celebrates Successful 65 Announces Definitive Agreements 65 Inks Licensing Agreement 65 Significantly Expand 65 Launches Generic Version 65 Canada Trading Halt 65 Acquires Stake 65 Offers Unique 65 Completes Buyout 65 Gets Approval 65 Announces Record Date 65 Sets Record Date 65 Solidifies 65 Extends Relationship 65 Releases Latest 65 Strengthens Commitment 65 Therapeutic Competitors Report 65 Proudly Announces 65 Sign Definitive Merger 65 Signs Contract 65 Receives Fast Track 65 Website Launched 65 Expands Offerings 65 L.P. Announces 65 Announces Refinancing 65 Reminds Shareholders 65 OTCBB IGXT 65 Validates 65 Drug Fails 65 researches develops licenses 65 OTCStockExchange.com Stock Alert 65 Announces Poster Presentations 64 Beefs Up 64 Q1 Profit Surges 64 Offers Affordable 64 MARKETING AGREEMENTS SOURCE 64 Shareholders Approve Merger Agreement 64 Acquire Majority Stake 64 Initiates 64 BayStreet.ca Research Alert 64 Evaluate Strategic Alternatives 64 Collaborators Publish 64 Director Exercises Options 64 Completes Refinancing 64 Jointly Launch 64 Earns Milestone Payment 64 Forms Strategic 64 Introduces Groundbreaking 64 Strengthens Leadership 64 Taps Into 64 Receives Authorization 64 Receives CE Marking 64 Jointly Offer 64 Host Fourth Quarter 64 Expands 64 Awarded Prestigious 64 Extends Relationship With 64 Flamel Technologies Announces 64 Expands Relationship 64 Directors Authorizes 64 Receive Milestone Payment 64 Doubles Size 64 Holds Annual Meeting 64 Signs Purchase Agreement 64 Announces Appointment 64 Study Indicates 64 Signs Reseller Agreement 64 Receives Shareholder Approval 64 Expects Higher 64 Debuts Next Generation 64 Announces Granting 64 Inc. LATEST NEWS 64 Completes Sale Of 64 Demonstrates Positive 64 Settles Patent Suit 64 Q4 Profit Rises 64 Introduces Unique 64 Announces 64 Diversifies 64 Completes Conversion 64 Concludes Successful 64 Q1 Adj 64 Enhances User Experience 64 Obtains Exclusive Rights 64 Misonix Announces 64 Bearish Speculation 64 FDA Accepts 64 Movers Roundup 64 Shareholders Approve 64 Elevates 64 Guides Inline 64 Posts Narrower Loss 64 Adopts Stockholder Rights 64 Completes Reorganization 64 Downtrend Spotted 64 Stock Downgraded 64 Expands Deployment 64 Renews Sponsorship 64 Evolves 64 otcstockexchange.com 64 Announce Reseller Agreement 64 Amplifies 64 Discloses 64 Identifies Key 64 CFO Resigns 64 Extend Relationship 64 BIOTECHNOLOGY SOURCE 64 Receives Funding 64 Q2 Profit Surges 64 MARKETING AGREEMENTS PRODUCT SOURCE 64 Posts Higher 64 Study Proves 64 Expands Scientific Advisory 64 Equipment Deals 64 Broadens 64 Ups Stake 64 Inks License 64 MERGERS ACQ SOURCE 64 Announce Interoperability 64 Cites Positive 64 www.shamrockstocks.com names 64 CRWEWallstreet.com Stock Report 64 Bolsters 64 Host Second Quarter 64 Announces Consummation 64 Signs Deal 64 Maintains Strong 64 Announce Merger 64 +#-#-#-# Ext [001] 64 Capital Invests 64 Patent Infringement Suit Against 64 Explores Strategic Alternatives 64 Enters Into Agreements 64 Provides Guidance 64 Summarizes 64 Extends Maturity 64 Provides Comprehensive 64 Announces Affiliation 64 Wins Prestigious 64 Establish Joint Venture 64 Improves Survival 64 Submits Bid 64 4Q Loss Widens 64 Announces Reverse Split 64 NewsBite Downgrade Puts Pressure 64 Reach Settlement 64 Q2 Profit Rises 64 Quadruples 64 Ink Pact 64 CybeRelease Gainers 64 Coverage Initiated 64 Q3 Profit Surges 64 SWOT Analysis Aarkstore Enterprise 64 StockGuru announces 64 Significantly Enhances 64 Enters Into Long Term 64 Therapeutic Competitors companiesandmarkets.com adEgemonye 64 CFO Exercises Options 64 -gamma secretase modulator 64 Receives Recognition 64 Flagship Product 64 Enters Into Partnership 64 Makes Debut 64 Q3 Adj 64 Bearish MACD 64 Completes 64 Subsidiary Expands 64 Ventures Invests 64 Redeems 64 Sharpens Focus 64 Wins Patent Infringement 64 Generic Version 64 Files Patent Infringement 64 Sells Itself 64 Finalizes Joint Venture 63 Proves Successful 63 Closes Over Allotment 63 Develops Novel 63 Celebrates Opening 63 VP Exercises Options 63 Restate Financials 63 Successfully Deploys 63 Registration Statement Declared Effective 63 Announces Stock Buyback 63 Commences Operations 63 Executes Letter 63 Q2 Profit Declines 63 Acquires Remaining 63 Bearish Pressure Building 63 Acquire 63 Appoints 63 Conference Call TRANSCRIPT 63 Renews Partnership 63 Starts Shipping 63 Study Demonstrates 63 Builds Momentum 63 CEO Exercises Options 63 Submits Proposal 63 Announces Dosing 63 Makes Bearish 63 Post Earnings Checkup 63 Reaffirms Commitment 63 Q3 Profit Soars 63 Proposed Buyout 63 Announces Favorable Ruling 63 Protects Against 63 Announces Debt Settlement 63 Strikes Deal 63 Patent Infringement Lawsuit Against 63 Announces Release Date 63 Settles Dispute 63 Engages 63 Receives Clearance From 63 Develops Breakthrough 63 Announce Breakthrough 63 Q3 Profit Rises 63 Expands Capacity 63 Bullish Engulfing Pattern 63 Q2 Adj 63 Receives Complete Response 63 Approves Share Repurchase 63 Q1 Profit Declines 63 Extends Contract 63 Establishes Joint Venture 63 Enters Into Distribution 63 Announces Spin Off 63 Q1 Profit Rises 63 Multi Billion Dollar 63 Report Examines 63 Files Revised 63 Successfully Tested 63 Oral Calcitonin 63 -Pahuta 63 Hold Fourth Quarter 63 Receives Coveted 63 Provides Operational Update 63 Supercharges 63 Inc. Nasdaq OXGN 63 Zacks Analyst Blog Highlights 63 Updates Guidance 63 Restate Financial 63 Showcases Next Generation 63 Amends Credit 63 Receives Stockholder Approval 63 Latest Addition 63 Subsidiary Awarded 63 Unveils Powerful 63 Study Links 63 Offers Unprecedented 63 Planned Acquisition 63 Platform Enables 63 Attracts Attention 63 Receives Prestigious 63 Confirms Filing 63 Signs MOU 63 Endures Analyst Downgrade 63 Broadens Product 63 Newly Acquired 63 Calls Purchased 63 Files Provisional 63 Commence Phase 63 Q3 Profit Declines 63 Q4 Profit Declines 63 Acquires Controlling Stake 63 Announces Pricing 63 Stock Upgraded 63 Q1 Profit Decreases 63 Recommences 63 Record Third Quarter 63 Delivers Unprecedented 63 Reports Second Quarter 63 Finalizes Contract 63 Retains CCG Investor Relations 63 Seek Shareholder Approval 63 Guides Below 63 Schedules Second Quarter 63 Breakthroughstocks.net EXPLOSIVE news 63 PRN FDA Approves 63 Lauches 63 Celebrates Decade 63 IND Application 63 Achieves ISO # 63 Announces Resignation 63 Milestone Payments 63 Pinnacle Digest Looking 63 Q4 Profit Plunges 63 Investigates Proposed Acquisition 63 Makes Splash 63 Accelerates Growth 63 Demonstrates Latest 63 Increases Capacity 63 Alert Technicals Showing Bearish 63 Enlarges 63 Achieves Certification 63 Study Validates 63 Awarded GSA Schedule 63 Presents Preclinical 63 Patents Covering 63 Q2 Profit Slips 63 Wins Coveted 63 Forges Strategic 63 www.shamrockstocks.com About 63 Sells Remaining 63 Announces Dividend 63 Delivers Strong 63 Underwriters Exercise 63 Uptrend Spotted 63 dedicated CHAT ROOM 63 Announce Successful Completion 63 Redefines 63 Generates Record 63 Declares Quarterly Dividends 63 Showcases Innovative 63 Declares Second Quarter 63 Daytradersdigest.com Profiles 63 :/ finance.yahoo.com q 63 Holds Promise 63 Increases Share Repurchase 63 Further Validates 63 Files Voluntary 63 Taro Receives 63 Expand Presence 63 Gets Clearance 63 Trend Continues Down 63 Provide Enhanced 63 Bullish Technical Alert 63 Extends Commitment 63 Buys Stake 63 Becomes Largest 63 DARA logo 63 Buys Into 63 Daytradersdigest.com 63 Named Fastest Growing 62 TheNewsWire Gainers 62 Releases Statement Regarding 62 Prescribes 62 Options Trader Alert 62 Schedules Investor 62 Announces Participation 62 Unlocks 62 Withdraws Application 62 Executes Definitive Agreement 62 Shareholders Approve Name 62 Closes Buyout 62 Releases Enhanced 62 Inc. PinkSheets QEDC 62 Ramps Up Production 62 IG HCR ;) CO 62 Lowers Guidance 62 Momentum Grows 62 Renews Multi 62 Q2 Profit Soars 62 Deloitte commends 62 Announces Reverse Merger 62 Successfully Integrates 62 Doubles Capacity 62 Beats Analyst 62 Receives Notice Regarding 62 Reinforces 62 Study Identifies 62 Withdraws Offer 62 Files Definitive Proxy 62 Settle Dispute 62 Resubmits 62 Sees Continued 62 Announces Restatement 62 Reports Third Quarter 62 Issues Clarification 62 Signs Non Binding 62 Files Resale 62 platform HDL Mimetic 62 Stock Soars 62 Releases Latest Version 62 Strengthens 62 Receives Approval From 62 News Unternehmensnachrichten 62 Teledyne Acquires 62 Helps Prevent 62 Terminate Agreement 62 Files Suit Against 62 Makes Strides 62 Enters Into Merger Agreement 62 Co. Initiates Independent 62 Shares Soar 62 Sees Significant 62 Genentech sanofi aventis 62 Sets Third Quarter 62 Develop Innovative 62 Expand Into 62 Signs Definitive Merger Agreement 62 SVP Exercises Options 62 Bullish Speculation 62 Wins Contract 62 Adds Depth 62 Hits Milestone 62 Files Annual Report 62 Study Examines 62 Continues Rapid 62 Commences Production 62 Issues Guidance 62 Receives Approvals 62 Alfa Wassermann 62 Has Commenced 62 commercialize telaprevir 62 Reach Agreement 62 Deliver Innovative 62 Subsidiary Awarded Contract 62 Expands Commitment 62 Downgrade Alert Watch 62 Unveils Enhanced 62 Increases Presence 62 Reports Significantly Improved 62 Effectively Treats 62 WeissComm Partners +#-#-#-# 62 PRNewsFoto 62 Pending Acquisition 62 Deliver Powerful 62 Accepted Into 62 Regains Nasdaq 62 Schedules Fiscal 62 Rolls Out 62 Report Analyzes 62 TRADESHOW SOURCE 62 Announces Operational Update 62 Reports Fiscal 62 Resolves Dispute 62 Takes Stake 62 Significant Increase 62 Revises Guidance 62 Reaches Settlement Agreement 62 Amends Private Placement 62 Receives Deficiency Letter 62 Technicals Showing Bullish